Release Date: 19/05/21 08:21 Summary: Half Year Results Presentation Price Sensitive: Yes Download Document 1.17MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%